Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Among biopharma firms, size didn’t always correlate with the highest wages, a recently debuted analysis of ‘best’ pharma ...

Having banked $60 million from Eli Lilly in the spring, Aktis Oncology has now closed an upsized $175 million series B that ...

At first glance, iGaming and pharmaceuticals might appear worlds apart. Yet, as regulated industries, they share significant ...

Teva Pharmaceutical Indus TEVA +2.72% Get Free Report has outperformed the market over the past 5 years by 6.63% on an ...

ARCH Venture Partners has raised $3 billion for a new fund — one of the largest in the biotech industry, and one the VC firm ...

The biotech stock's price-to-earnings-to-growth (PEG) ratio is a super-low 0.58, according to the London Stock Exchange Group ...

Analyst Kostas Biliouris of BMO Capital maintained a Hold rating on BridgeBio Pharma (BBIO – Research Report), retaining the price target ...

-- 18,500m2 area being remade into state-of-the-art facility dedicated to life sciences and pharmaceuticals to provide higher ...

In the U.K., a pharma-run watchdog has been issuing fines and levying suspensions. Could this help build public trust?

Surveys show strong bipartisan support for Medicare to negotiate prescription prices, and research supports the benefits for ...

In terms of liquidity and interest, the mean open interest for Biomarin Pharmaceutical options trades today is 583.17 with a ...